Aspectos farmacocinéticos de bevacizumab
2013
Angiogenesis is a process that involves the growth of new blood vessels from pre-existing vasculature. Vascular endothelial growth factor (VEGF) is the key signal used to promote growth of blood vessels. Bevacizumab is a humanized monoclonal antibody that inhibits the angiogenesis process. This review has the purpose to expose some pharmaceutical aspects of bevacizumab.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
10
References
0
Citations
NaN
KQI